La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Zhejiang CONBA PharmaceuticalLtd Bilan de santé
Santé financière contrôle des critères 6/6
Zhejiang CONBA PharmaceuticalLtd has a total shareholder equity of CN¥7.5B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are CN¥11.3B and CN¥3.8B respectively. Zhejiang CONBA PharmaceuticalLtd's EBIT is CN¥533.4M making its interest coverage ratio -4.9. It has cash and short-term investments of CN¥2.4B.
Informations clés
14.2%
Ratio d'endettement
CN¥1.06b
Dette
| Ratio de couverture des intérêts | -4.9x |
| Argent liquide | CN¥2.37b |
| Fonds propres | CN¥7.47b |
| Total du passif | CN¥3.84b |
| Total des actifs | CN¥11.31b |
Mises à jour récentes de la santé financière
Analyse de la situation financière
Passif à court terme: 600572's short term assets (CN¥5.9B) exceed its short term liabilities (CN¥3.0B).
Passif à long terme: 600572's short term assets (CN¥5.9B) exceed its long term liabilities (CN¥813.1M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 600572 has more cash than its total debt.
Réduire la dette: 600572's debt to equity ratio has reduced from 56.4% to 14.2% over the past 5 years.
Couverture de la dette: 600572's debt is well covered by operating cash flow (92.2%).
Couverture des intérêts: 600572 earns more interest than it pays, so coverage of interest payments is not a concern.